Oct 12, 2011 ... Noritaka Komune, Takeshi Ichinohe,* Minako Ito, and Yusuke Yanagi*. 3. 4.
Department of Virology, Faculty of Medicine, Kyushu University, ...
JVI Accepts, published online ahead of print on 12 October 2011 J. Virol. doi:10.1128/JVI.05942-11 Copyright © 2011, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights Reserved.
1
Measles virus V protein inhibits NLRP3 inflammasome-mediated IL-1β secretion
2 3
Noritaka Komune, Takeshi Ichinohe,* Minako Ito, and Yusuke Yanagi*
5
Department of Virology, Faculty of Medicine, Kyushu University, Fukuoka 812-8582,
6
Japan
7 8
Running title: INFLAMMASOME ACTIVATION BY MEASLES VIRUS
9 10
Word count of the abstract: 217
11
Word count of the text: 4,136
12 13
*Corresponding author. Mailing address for Takeshi Ichinohe: Department of Virology,
14
Faculty of Medicine, Kyushu University, Fukuoka 812-8582, Japan. Phone:
15
81-92-642-6138. Fax: 81-92-642-6140. E-mail:
[email protected].
16
Mailing address for Yusuke Yanagi: Department of Virology, Faculty of Medicine, Kyushu
17
University, Fukuoka 812-8582, Japan. Phone: 81-92-642-6135. Fax: 81-92-642-6140.
18
E-mail:
[email protected].
19 1
Downloaded from http://jvi.asm.org/ on November 1, 2017 by guest
4
20
ABSTRACT
21 22
Inflammasomes are cytosolic protein complexes that stimulate the activation of caspase-1, which in turn induces the secretion of the inflammatory cytokines interleukin
24
(IL)-1β and IL-18. Recent studies have indicated that the NOD-like receptor family, pyrin
25
domain containing 3 (NLRP3) inflammasome recognizes several RNA viruses, including
26
the influenza and encephalomyocarditis viruses, whereas the retinoic acid-inducible gene I
27
(RIG-I) inflammasome may detect vesicular stomatitis virus. We demonstrate that measles
28
virus (MV) infection induces the caspase-1-dependent IL-1β secretion in the human
29
macrophage-like cell line THP-1. Gene knockdown experiments indicated that IL-1β
30
secretion in MV-infected THP-1 cells was mediated by the NLRP3 inflammasome, but not
31
the RIG-I inflammasome. MV produces the non-structural V protein that has been shown to
32
antagonize host innate immune responses. The recombinant MV lacking the V protein
33
induced more IL-1β compared with the parental virus. THP-1 cells stably expressing the V
34
protein suppressed NLRP3 inflammasome-mediated IL-1β secretion. Furthermore,
35
co-immunoprecipitation assays revealed that the V protein interacts with NLRP3 through
36
its carboxyl terminal domain. NLRP3 was located in cytoplasmic granular structures in
37
THP-1 cells stably expressing the V protein, but upon inflammasome activation, NLRP3
2
Downloaded from http://jvi.asm.org/ on November 1, 2017 by guest
23
38
was redistributed to the perinuclear region where it co-localized with the V protein. These
39
results indicate that the V protein of MV suppresses NLRP3 inflammasome-mediated IL-1β
40
secretion by directly or indirectly interacting with NLRP3.
Downloaded from http://jvi.asm.org/ on November 1, 2017 by guest
41
3
42
INTRODUCTION
43 44
Measles is an acute contagious disease that remains a major cause of childhood mortality worldwide, especially in developing countries (6). Measles virus (MV), a member of the
46
family Paramyxoviridae, is an enveloped virus with a non-segmented single-stranded
47
negative-sense RNA genome (15). Upon MV infection, cells produce interferon (IFN)-α/β
48
following recognition of the virus by RNA helicases retinoic acid-inducible gene I (RIG-I)
49
and melanoma differentiation-associated gene 5 (MDA5) (22, 43) or Toll-like receptor
50
(TLR) 7 (51). MV encodes Phospho (P), V and C proteins, which can counteract the host
51
IFN response (11, 34, 36, 54, 64). Among these viral proteins, the V protein is the most
52
versatile antagonist. It blocks IFN-α/β signal transduction in infected cells (9, 11, 13, 36,
53
38, 47, 59, 64) and inhibits TLR7-mediated IFN-α production in human plasmacytoid
54
dendritic cells (42). Furthermore, the MV V protein, like that of other paramyxoviruses,
55
interacts with MDA5, and inhibits its function with respect to IFN induction (2). The
56
N-terminal domain of the V protein (Vn), which is common to the P and V proteins, has
57
been shown to interact with signal transducers and activators of transcription (STAT)1 and
58
Jak1, which are involved in IFN signaling (9), whereas the unique cysteine-rich C-terminal
59
domain of the V protein (Vc) was found to interact with MDA5 (39), STAT2 (47), and IκB
4
Downloaded from http://jvi.asm.org/ on November 1, 2017 by guest
45
kinase α (IKKα), which is involved in the activation of interferon regulatory factor 7
61
through TLR7 (42). Furthermore, Vc interacts with the NF-κB subunit p65 (RelA) to
62
suppress NF-κB activity (53). The mechanism by which the MV C protein acts as an IFN
63
antagonist is not well understood, but it probably suppresses IFN induction by regulating
64
viral RNA synthesis (34).
65
Secretion of the inflammatory cytokines interleukin (IL)-1β and IL-18 is tightly
66
regulated by the inflammasomes, caspase-1 activating molecular complexes (32).
67
Recognition of pathogens by pattern recognition receptors such as TLRs induces pro-IL-1β
68
and pro-IL-18 in the cytoplasm. The activation of the inflammasomes leads to the
69
conversion of procaspase-1 to caspase-1, which cleaves pro-cytokines into mature IL-1β
70
and IL-18 that are then secreted. The best characterized inflammasome is the NOD-like
71
receptor (NLR) family, pyrin domain containing 3 (NLRP3, also known as Nalp3 or
72
cryopyrin) inflammasome, which can be activated by a wide range of stimuli such as
73
endogenous danger signals from damaged cells, bacterial components, and environmental
74
irritants (52).
75
Infection by RNA viruses such as influenza virus (1, 19, 20, 61), encephalomyocarditis
76
virus (EMCV) (44, 45) and vesicular stomatitis virus (VSV) (45) also stimulates NLRP3,
77
which then recruits the apoptosis-associated speck-like protein containing a
5
Downloaded from http://jvi.asm.org/ on November 1, 2017 by guest
60
caspase-recruitment domain (ASC) and procaspase-1, forming the NLRP3 inflammasome.
79
How RNA viruses are recognized by NLRP3 is not well known, but in the case of influenza
80
virus, the proton-selective ion channel M2 protein, not genomic RNA, has been shown to
81
stimulate the NLRP3 inflammasome pathway (20). One study reported that infection with
82
VSV or transfection with 5’-triphosphate RNA activates the RIG-I inflammasome (44).
83
Furthermore, absent in melanoma 2 (AIM2) binds to dsDNA and engages the adaptor
84
protein ASC to form a caspase-1-activating inflammasome (7, 12, 18, 50). Experiments
85
using AIM2-deficient mice revealed that AIM2 is essential in regulating
86
caspase-1-dependent maturation of IL-1β and IL-18 in response to dsDNA, as well as DNA
87
viruses such as vaccinia virus and mouse cytomegalovirus (49).
88
In the present study, we show that MV induces secretion of IL-1β in human
89
macrophage-like cells. By generating NLRP3 and RIG-I knockdown cells, we also
90
demonstrate that MV activates the NLRP3 inflammasome, which results in
91
caspase-1-mediated maturation of IL-1β. Furthermore, our results indicate that the MV V
92
protein has the ability to interact with NLRP3 through its C-terminal domain, thereby
93
inhibiting NRLP3 inflammasome-mediated IL-1β secretion.
94 95
MATERIALS AND METHODS
6
Downloaded from http://jvi.asm.org/ on November 1, 2017 by guest
78
96 97
Cells and viruses. Vero cells constitutively expressing human signaling lymphocyte activation molecule (SLAM; Vero/hSLAM cells) (37) and HEK293T cells were maintained
99
in Dulbecco’s modified Eagle’s medium (DMEM; Wako Pure Chemical Industry)
100
supplemented with 7.5% (vol/vol) fetal bovine serum (FBS). PLAT-gp cells (a gift from M.
101
Shimojima and T. Kitamura) containing the retroviral gag and pol genes (33) were
102
maintained in DMEM supplemented with 7.5% FBS and blasticidin (10 μg/ml; Invitrogen).
103
Human monocytic THP-1 cells were cultured in RPMI-1640 medium (Wako Pure Chemical
104
Industry) containing L-glutamine (2 mM; Nacalai Tesque), 2-mercaptoethanol (50 μM;
105
Nacalai Tesque) and 10% (vol/vol) FBS. For macrophage differentiation, THP-1 cells were
106
treated with phorbol 12-myristate 13-acetate (0.5 μM; PMA) (Sigma) at 37ºC for 3 h. Cell
107
surface expression of SLAM on THP-1 cells was examined by flow cytometry analysis
108
using an anti-SLAM monoclonal antibody IPO-3 (Cayman Chemical). IC323-EGFP (17)
109
and MV-ΔV (22) are enhanced green fluorescent protein (EGFP)-expressing recombinant
110
viruses based on a wild-type IC-B strain of MV. MV-∆V was generated by introducing four
111
nucleotide substitutions into the region corresponding to the RNA editing motif of the P
112
gene of IC323-EGFP. All four substitutions were synonymous in the reading frame of the P
113
protein. Viruses were titrated on Vero/hSLAM cells. UV-inactivation was performed by
7
Downloaded from http://jvi.asm.org/ on November 1, 2017 by guest
98
114
exposing viruses to 1.0 J of UV light/cm2 with a Stratalinker® UV cross-linker (Stratagene). Plasmid constructions. pCA7-Flag-MDA5 was generated by inserting Flag-tagged
116
MDA5 from pEF-Flag-MDA5 (34) into the expression vector pCA7 (58). The cDNA for
117
human NLRP3 was purchased from the National Institute of Technology and Evaluation,
118
Biological Resource Center, Japan. The cDNAs encoding human ASC, procaspase-1, and
119
pro-IL-1β were obtained by reverse transcription of total RNA from lipopolysaccharide
120
(LPS)-treated THP-1 cells, followed by PCR using specific primers. These cDNAs were
121
cloned into pCA7 (pCA7-NLRP3, pCA7-ASC, pCA7-procaspase-1, and pCA7-
122
pro-IL-1β) or pCA7-Flag to produce Flag-tagged proteins (pCA7- Flag- NLRP3 and
123
pCA7-Flag-ASC). pCAG-HA-IC-V and pCAG-HA-IC-Vn were generated by inserting the
124
DNA fragments encoding the HA-tagged full length V protein from the IC-B strain of MV
125
and the truncated V protein containing only the N-terminal 231 residues (36) into pCAGGS
126
(35), respectively. pCA7-HA-orange-Vc, pCA7-HA-orange-Vc(C272R), pCA7-IC-V and
127
pCA7-EGFP were generated by inserting the DNA fragments encoding the HA-tagged
128
kusabira-orange-fused C-terminal 69 residues of the V protein (orange-Vc), orange-Vc with
129
the C272R substitution (orange-Vc(C272R)), the full length V protein, and EGFP into
130
pCA7, respectively.
131
Knockdown of genes using short hairpin (sh) RNA. Using the pRS-U6/puro vector
8
Downloaded from http://jvi.asm.org/ on November 1, 2017 by guest
115
(OriGene), plasmids pRS-shNLRP3, pRS-shRIG-I and pRS-shEGFP were constructed.
133
They expressed shRNAs targeting human NLRP3, human RIG-I and EGFP mRNAs,
134
respectively. Target sequences were designed using BLOCK-iT RNAi Designer
135
(Invitrogen) or had been described previously (22, 63): 5’-GGA GAG ACC TTT ATG AGA
136
AAG-3’ for NLRP3, 5’-GCC AGA ATG TTA GTG AGA ATT-3’ for RIG-I, and 5’-GGC
137
ACA AGC TGG AGT ACA ACT-3’ for EGFP. To generate shRNA-expressing retroviruses,
138
PLAT-gp cells in 10-cm dishes were transfected with 20 μg of each shRNA-expressing
139
plasmid and 2 μg of pCVSV-G encoding the VSV G protein (55) using PEI-Max
140
(Polysciences, Inc). Culture medium was replaced with fresh medium 6 h later, and
141
supernatants containing retroviruses were collected at 48 h post-transfection. To generate
142
THP-1 cells constitutively expressing shRNA targeting NLRP3, RIG-I and EGFP,
143
respectively, 4 × 105 THP-1 cells in 200 μl complete medium were centrifuged with each
144
shRNA-expressing retrovirus (200 μl) containing polybrene (10 μg/ml) at 370 × g at room
145
temperature for 90 min. Then, 24 h later, the transduction was repeated to enhance virus
146
infection, and cells were incubated for a further 24 h in the presence of polybrene. Cells
147
were cultured for 2–3 weeks in medium containing puromycin (0.5 μg/ml) to kill
148
non-transduced cells.
149
Generation of cells stably expressing the MV V protein. To generate the retrovirus
9
Downloaded from http://jvi.asm.org/ on November 1, 2017 by guest
132
expressing the MV V protein, the cDNA encoding the V protein of the IC-B strain of MV
151
was cloned into pMXs-GFP (a gift from M. Shimojima and T. Kitamura) (27), producing
152
pMX-V. PLAT-gp cells were transfected with 20 μg of pMX-V and 2 μg of pCVSV-G using
153
PEI-Max, and the retrovirus was recovered. Cells in 24-well plates were centrifuged with
154
200 μl of medium containing the retrovirus expressing the MV V protein and polybrene (10
155
μg/ml) at 370 × g for 90 min at room temperature. At 24 h after transduction, culture
156
medium was replaced with complete RPMI-1640 medium containing puromycin (0.5
157
μg/ml). A single clone was isolated from puromycin-resistant clones that formed colonies in
158
methyl cellulose medium. As a control, cells stably expressing EGFP were also generated
159
as above.
160
MV infection. Cells were infected with MV at a multiplicity of infection (MOI) of 0.1 or
161
influenza virus PR8 at an MOI of 2 for 2 h at 37°C, washed with phosphate-buffered saline
162
(PBS), and cultured with complete RPMI medium for 24–48 h. To inhibit caspase-1
163
activation, cells were pretreated with 5 μM Ac-YVAD-CHO (Bachem) for 30 min. Then,
164
the cells were infected with MV in the presence of Ac-YVAD-CHO for 2 h at 37°C, washed
165
with PBS, and cultured with complete RPMI medium containing Ac-YVAD-CHO.
166 167
Measurement of IL-1β and pro-IL-1β. Cell-free supernatants were collected at 24–48 h post-infection, at 24 h following transfection with poly(dA:dT) (Invitrogen) or at 24 h after
10
Downloaded from http://jvi.asm.org/ on November 1, 2017 by guest
150
stimulation with LPS plus ATP. The supernatants were analyzed for the presence of IL-1β
169
using an enzyme-linked immunosorbent assay (ELISA) utilizing paired antibodies
170
(eBiosciences) (20). To measure intracellular pro-IL-1β, cells were lysed by repeated cycles
171
of freezing and thawing in PBS containing 2% FBS, and the lysates were analyzed by
172
ELISA (44).
173
Reconstitution of the NLRP3 inflammasome in HEK293T cells. HEK293T cells
174
grown to approximately 60% confluency in 24-well plates were transfected with 15 ng of
175
pCA7-NLRP3, 5 ng of pCA7-ASC, 5 ng of pCA7-procaspase-1, 150 ng of
176
pCA7-pro-IL-1β, and either 600 ng of pCA7-IC-V or 600 ng of pCA7-EGFP using
177
PEI-Max. Cell-free supernatants were collected 24 h after transfection and analyzed for
178
IL-1β by ELISA. Under this condition, exclusion of any one of the expression plasmids
179
encoding ASC, procaspase-1 or pro-IL-1β led to no production of IL-1β (data not shown).
180
Co-immunoprecipitation and western blot analyses. Sub-confluent monolayers of
181
HEK293T cells in 6-well plates were transfected with 6 μg of pCA7-Flag-NLRP3, 2 μg of
182
pCA7-Flag-ASC, or 6 μg of pCA7-Flag-MDA5 together with 2 μg of pCAG-HA-IC-V, 2
183
μg of pCAG-HA-IC-Vn, 2 μg of pCA7-HA-orange-Vc, or 2 μg of
184
pCA7-HA-orange-Vc(C272R). At 48 h post-transfection, the cells were washed with PBS
185
and lysed in 1 ml of co-immunoprecipitation buffer [50 mM Tris pH 8.0, 280 mM NaCl,
11
Downloaded from http://jvi.asm.org/ on November 1, 2017 by guest
168
0.5% NP-40, 0.2 mM EDTA, 2 mM EGTA, 10% glycerol, 1 mM dithiothreitol (DTT)] (29)
187
containing protease inhibitors (Sigma). The lysates were centrifuged at 20,630 × g for 90
188
min at 4°C. A small amount (50 μl) of each supernatant was mixed with sodium dodecyl
189
sulfate (SDS) loading buffer (50 mM Tris pH 6.8, 100 mM DTT, 2% SDS, 0.1%
190
bromophenol blue, 10% glycerol), and boiled for 5 min. The rest of the supernatant was
191
incubated for 90 min at 4°C with protein A-Sepharose (GE Healthcare AB), which had been
192
pretreated with an anti-Flag (F1804, Sigma) or anti-HA (sc-7392, Santa Cruz) antibody for
193
90 min at 4°C. Complexes with the sepharose were obtained by centrifugation and washed
194
three times with co-immunoprecipitation buffer. The polypeptides in the precipitated
195
complexes were fractionated by SDS-polyacrylamide gel electrophoresis (PAGE) using
196
10–15% polyacrylamide gel and electroblotted onto polyvinylidene difluoride (PVDF)
197
membranes (Hybond-P, Amersham Biosciences). The membranes were incubated with
198
anti-Flag (F7425, Sigma) or anti-HA antibody (561, Medical & Biological Laboratories Co),
199
followed by incubation with horseradish peroxidase-conjugated anti-rabbit IgG (Invitrogen)
200
for detection of the Flag-tagged or HA-tagged proteins.
201
To detect the cleaved form of IL-1β, the supernatant was incubated for 90 min at 4°C
202
with Dynabeads® Pan Mouse IgG (Invitrogen), which had been pretreated with a mouse
203
monoclonal antibody against human IL-1β (clone 8516.311; R&D System, Inc.) for 90 min
12
Downloaded from http://jvi.asm.org/ on November 1, 2017 by guest
186
at 4°C. Complexes with the beads were obtained using magnets, and washed with 1× RIPA
205
buffer (150 mM NaCl, 0.1% SDS, 1% deoxycholate, 1% Triton X-100 and 10 mM Tris pH
206
7.4) (29). For immunoblotting, a mouse anti-human IL-1β monoclonal antibody (MAB201,
207
R&D) was used in Can Get Signal® solution 1 (TOYOBO) followed by a horseradish
208
peroxidase-conjugated secondary antibody diluted in Can Get Signal® solution 2. To detect
209
human NLRP3, RIG-I, β-actin, and MV V protein, cells were lysed in 1× RIPA buffer. The
210
lysates were subjected to SDS-PAGE under reducing conditions and subsequently blotted
211
using the indicated antibodies: human NLRP3 (AG-20B-0014-C100; AdipoGen), human
212
RIG-I (54285; AnaSpec), β-actin (sc-8432; Santa Cruz) and MV V protein (34). The PVDF
213
membranes were treated with Chemi-Lumi One Super (Nacalai Tesque) to elicit
214
chemiluminescent signals, and the signals were detected and visualized using a VersaDoc
215
3000 imager (Bio-Rad).
216
Immunofluorescence staining. Cells were fixed and permeabilized with PBS containing
217
2.5% formaldehyde and 0.5% Triton X-100. The fixed cells were washed with PBS and
218
then incubated with a primary antibody against NLRP3 (AG-20B-0014-C100) or MV V
219
protein for 1 h at room temperature, followed by incubation with Alexa Fluor
220
488-conjugated donkey anti-mouse IgG (H+L; Invitrogen) or Alexa Fluor 594-conjugated
221
donkey anti-rabbit IgG (H+L; Molecular Probes) for 1 h at room temperature. The stained
13
Downloaded from http://jvi.asm.org/ on November 1, 2017 by guest
204
222 223 224
cells were observed using a confocal microscope (Radiance 2100, Bio-Rad). Statistics. Data were analyzed for statistical significance using a two-tailed Student’s t-test. P-values less than 0.05 were considered statistically significant.
226
RESULTS
227 228
MV induces IL-1β in PMA-stimulated THP-1 cells. The human monocytic cell line
229
THP-1 is differentiated into macrophage-like cells by stimulation with PMA (40, 62).
230
THP-1 cells had little expression of SLAM, the principal cellular receptor for MV (60), but
231
its expression level was elevated after stimulation with PMA (Fig. 1A). Infection of
232
PMA-stimulated THP-1 cells (THP-1/PMA cells) with MV (IC323-EGFP) induced IL-1β
233
secretion in the supernatant at 24 h post-infection, similar to that with the PR8 strain of
234
influenza virus (1) (Fig. 1B). Secretion of IL-1β in MV-infected THP-1/PMA cells was
235
increased in a time- (Fig. 1C) and MOI-dependent manner (Fig. 1D). Western blot analysis
236
demonstrated that the p17 subunit, the mature processed form of IL-1β, was secreted in the
237
supernatant (Fig. 1D). Furthermore, YVAD-CHO, a specific inhibitor of caspase-1,
238
suppressed IL-1β production in MV-infected THP-1/PMA cells without affecting the
239
amounts of pro-IL-1β in the cytosol (Fig. 1E). In order to examine whether viral replication
14
Downloaded from http://jvi.asm.org/ on November 1, 2017 by guest
225
is required to induce IL-1β, we infected THP-1/PMA cells with UV-treated or untreated
241
MV. Infection with UV-treated MV failed to induce IL-1β secretion (Fig. 1F), indicating
242
that viral particles or genomic RNA are not sufficient to stimulate IL-1β secretion. Together,
243
these results indicate that infection with live MV causes caspase-1-dependent IL-1β
244
secretion in THP-1/PMA cells.
245
MV activates the NLRP3 inflammasome. To evaluate individual contributions of
246
NLRP3 and RIG-I inflammasomes to the induction of IL-1β after MV infection, we
247
generated THP-1 cells stably expressing shRNA against human NLRP3 or RIG-I. Western
248
blot analysis confirmed knockdown of NLRP3 and RIG-I in respective shRNA-expressing
249
THP-1/PMA cells at 24 h after LPS stimulation (Fig. 2A). Expression levels of NLRP3 and
250
RIG-I in knockdown cells were 16% and 18% (after normalization using expression levels
251
of β-actin), compared with those in control cells, respectively. As expected, IL-1β secretion
252
induced with LPS (an inducer of pro-IL-1β) plus ATP (an NLRP3 agonist), was
253
significantly reduced in NLRP3 knockdown cells, but not in RIG-I knockdown cells (Fig.
254
2B). NLRP3, but not RIG-I, knockdown THP-1/PMA cells secreted a lower amount of
255
IL-1β in the supernatant at 24 h after MV infection, compared with THP-1/PMA cells
256
expressing a control shRNA (shEGFP) (Fig. 2C). Reduction of IL-1β production was not
257
because of a general defect in the cytokine response of NLRP3 knockdown cells. After
15
Downloaded from http://jvi.asm.org/ on November 1, 2017 by guest
240
dsDNA-dependent activation of the AIM2 inflammasome, they produced a comparable
259
level of IL-1β with control and RIG-I knockdown cells (Fig. 2D). These results indicate
260
that the NLRP3 inflammasome, but not the RIG-I inflammasome, is involved in
261
MV-induced IL-1β production in THP-1/PMA cells.
262
MV V protein inhibits MV-induced IL-1β secretion. The MV V protein counteracts
263
the IFN-α/β-induced antiviral activity through several different mechanisms (2, 9, 11, 38,
264
47, 59, 64). The inflammasomes, along with the IFN system, play an important role in
265
innate immunity, and we suspected that the V protein may also possess the activity to block
266
inflammasome activation. To test this hypothesis, two sets of experiments were performed.
267
First, we examined the effect of the V protein on IL-1β secretion of HEK293T cells
268
transiently transfected with plasmids encoding components of the NLRP3 inflammasome:
269
NLRP3, ASC, procaspase-1, and pro-IL-1β (10). In this experiment, HEK293T cells were
270
used as they are human cells that can be transfected at a high efficiency. Furthermore
271
HEK293T cells are deficient in endogenous ASC and NLRP3 (5). Reconstitution of the
272
NLRP3 inflammasome resulted in IL-1β secretion by HEK293T cells, in which NLRP3
273
was absolutely required (Fig. 3A). Inclusion of the MV V protein inhibited IL-1β secretion
274
by ~30%. Second, we established THP-1 cells stably expressing the MV V protein
275
(THP-1/MV-V cells) (Fig. 3B). THP-1/MV-V/PMA cells secreted significantly lower
16
Downloaded from http://jvi.asm.org/ on November 1, 2017 by guest
258
amounts of IL-1β in response to LPS plus ATP compared with control cells
277
(THP-1/EGFP/PMA cells) (Fig. 3C), indicating that the V protein blocks NLRP3
278
inflammasome activation. In contrast, IL-1β production in response to poly(dA:dT) was
279
comparable between THP-1/MV-V/PMA and control cells (Fig. 3D), indicating that the
280
IL-1β secretion pathway, including the level of pro-IL-1β, is not generally affected in
281
THP-1/MV-V/PMA cells. Thus, the inhibitory activity of the V protein appears to be
282
specific for the NLRP3 inflammasome.
283
Next, we examined IL-1β production in THP-1/PMA cells infected with MV
284
(IC323-EGFP) and its mutant recombinant virus lacking the V protein (MVΔV) (22). As
285
expected, the amount of IL-1β in the supernatant at 24 h after MVΔV infection was about
286
5-fold higher than that after MV infection (Fig 3E). The modest increase in the amount of
287
intracellular pro-IL-1β in MVΔV-infected cells alone unlikely explains the increase in
288
IL-1β secretion. Taken together, all these results indicate that the MV V protein blocks
289
NLRP3 inflammasome activation.
290
The MV V protein interacts with NLRP3. To gain an insight into the mechanism by
291
which the V protein inhibits NLRP3 inflammasome activation, co-immunoprecipitation
292
experiments were performed using Flag- and HA-tagged proteins in HEK293T cells that
293
can be transfected at a high efficiency (Fig. 4A). The MV V protein has been shown to
17
Downloaded from http://jvi.asm.org/ on November 1, 2017 by guest
276
interact with MDA5 (2), and this interaction was used as a positive control. The V protein
295
was found to co-immunoprecipitate with NLRP3, when HEK293T cells were transfected
296
with plasmids encoding these two proteins (Fig. 4A). However, the V protein did not
297
co-immunoprecipitate with ASC, a component of the NLRP3 inflammasome. To further
298
dissect the interaction between the V protein and NLRP3, Vn and Vc were examined for
299
their activity. Consistent with previous reports (2, 39), the full-length V protein and Vc, but
300
not Vn, interacted with MDA5 (Fig. 4B upper and lower). Similarly, the V protein and Vc,
301
but not Vn, co-immunoprecipitated with NLRP3 (Fig. 4B middle and lower). Vc with the
302
C272R substitution, which is unable to bind to MDA5 (57), was expressed at a reduced
303
level compared with the intact Vc, but nevertheless co-immunoprecipitated with NLRP3
304
(Fig. 4C), indicating that the site on the V protein used to interact with NLRP3 is different
305
from that with MDA5.
306
Next, we examined intracellular localizations of the V protein and NLRP3 in
307
THP-1/MV-V/PMA cells. Under non-stimulatory conditions, most of the NLRP3 protein
308
was found to be localized in granular cytoplasmic structures (Fig. 4D). Consistent with a
309
previous report (38), the MV V protein was found in both the nucleus and cytoplasm. This
310
pattern of localization greatly changed after NLRP3 inflammasome activation by LPS plus
311
ATP. NLRP3 was relocated to the perinuclear region, and co-localized with the V protein.
18
Downloaded from http://jvi.asm.org/ on November 1, 2017 by guest
294
312 313
DISCUSSION
314
In the present study, we show that MV-infected human macrophage-like THP-1 cells
316
secrete IL-1β through the activation of the NLRP3 inflammasome, and that the MV V
317
protein has the ability to interact with NLRP3 through its C-terminal domain, thereby
318
inhibiting NRLP3 inflammasome-mediated IL-1β secretion.
319
A number of viruses induce the production of IL-1β in infected cells. Infection with RNA
320
viruses such as influenza virus (1, 19, 20, 61) and EMCV (44, 45) has been shown to cause
321
IL-1β secretion via NLRP3 inflammasome activation. Poeck et al. reported that VSV or
322
5’-triphosphate RNA triggers RIG-I inflammasome activation and IL-1β secretion (44);
323
however, a recent report demonstrated that VSV activates the NLRP3 inflammasome
324
independently of RIG-I and MDA5 (45). Our results also show that IL-1β secretion in
325
MV-infected cells is mediated by the NLRP3 inflammasome, but not the RIG-I
326
inflammasome. Thus, the NLRP3 inflammasome appears to play a central role in
327
caspase-1-dependent IL-1β secretion after infection with RNA viruses.
328 329
Although RIG-1 and AIM2 are known to recognize viral nucleic acids, how NLRP3 detects viruses has not been clearly shown. In our experiments, UV-inactivated MV did not
19
Downloaded from http://jvi.asm.org/ on November 1, 2017 by guest
315
induce IL-1β in infected cells, suggesting that newly produced MV transcripts, genomic
331
RNA and/or proteins are responsible for NLRP3 inflammasome activation. Because
332
expression of the influenza virus M2 protein alone can cause NLRP3 inflammasome
333
activation (20), the disturbance in the intracellular ionic milieu accompanying viral
334
infection rather than viral nucleic acids may be important in this process.
335
Viruses usually possess strategies to counteract the IFN response (14, 25, 48). Several
336
viruses are also known to encode proteins that interfere with IL-1β production. For example,
337
myxoma and Shope fibroma viruses encode the pyrin domain-containing protein that
338
interacts with ASC and inhibits inflammasome activation (23). Vaccinia, cowpox and
339
myxoma viruses encode the serpin-like protease inhibitor, which specifically binds to
340
caspase-1 and inhibits pro-IL-1β cleavage (26, 28, 41). Furthermore, the influenza virus
341
NS-1 protein prevents caspase-1 activation and IL-1β production by unknown mechanisms
342
(56). Our data indicated that the MV V protein interacts with NLRP3 through its C terminal
343
domain and inhibits NLRP3 inflammasome-mediated IL-1β secretion. Because the MV V
344
protein did not inhibit dsDNA-dependent AIM2 inflammasome activation, it must act
345
specifically on NLRP3. A Basic Local Alignment Search Tool for protein (BLASTP)
346
revealed that the MV V protein and NLRP3 do not have any homologous regions,
347
indicating that the interaction is not dependent on the homologous conserved sequences.
20
Downloaded from http://jvi.asm.org/ on November 1, 2017 by guest
330
Recently, IFN-α/β signaling was shown to inhibit NLRP1 and NLRP3 inflammasome
349
activation via the STAT1 transcription factor (16). As NLRP3 inflammasome-dependent
350
IL-1β maturation occurs in MV-infected THP-1 cells, MV (IC323-EGFP) may induce only
351
marginal amounts of IFN-α/β insufficient to inhibit NLRP3 inflammasome
352
activation. Alternatively, IFN signaling may be sufficiently suppressed by MV P/V/C
353
proteins. Then, it could be expected that MVΔV fails to activate the NLRP3 inflammasome,
354
because the V protein blocks STAT1 phosphorylation (9, 11, 59, 64), and its absence in
355
MVΔV would lead to enhanced IFN signaling. However, infection with MVΔV led to
356
increased IL-1β secretion (Fig. 3E). This is explained by our finding that the V protein
357
inhibits NLRP3 inflammasome activation by interacting with NLRP3. The MV V protein
358
comprises Vn and Vc, and has many interacting partners in host cells. Vn interacts with
359
STAT1 and Jak1 (9), whereas Vc does so with NLRP3, MDA5 (2), STAT2 (38, 47), IKKα
360
(42), and NF-κB p65 (53). All these partner proteins are involved in anti-viral responses,
361
and the V protein interacts with these proteins differently, as exemplified by the V protein
362
with the C272R substitution. Based on the crystal structure of the parainfluenza virus 5
363
(PIV5) V protein (31), it was predicted that MV Vc also forms two loops that coordinate
364
two zinc ions via one histidine and seven cycteine residues (8, 46). The first loop is likely
365
formed by H232, C251, C276, and C279, and the second loop by the central cysteines
21
Downloaded from http://jvi.asm.org/ on November 1, 2017 by guest
348
(C255, C267, C269, and C272). The substitution of the C251, C255, and C272 in the MV V
367
protein has been reported to disrupt its interaction with MDA5(46, 57), suggesting that both
368
loops are important for the interaction of the MV V protein with MDA5. On the other hand,
369
our results showed that a mutation in C272 does not affect the interaction of Vc with
370
NLRP3. This may suggest that the intact first loop of Vc is sufficient for its interaction with
371
NLRP3. Furthermore, two conserved tryptophan residues (W240 and W250), F246, and
372
D248 have been shown to be critical for the interaction of the MV V protein with STAT2 (8,
373
47). Taken together, Vc is likely to interact with a variety of host proteins through its
374
multiple interfaces.
375
The V protein inhibits NF-κB as well as MDA5 involved in the production of NF-κB and
376
IFN-α/β. Importantly, NF-κB signaling leads to the up-regulated transcription of pro-IL-1β
377
(3). Thus, the MV V protein may not only inhibit NLRP3 inflammasome activation by
378
interacting with NLRP3, but also by suppressing NF-κB p65 and MDA5. During the course
379
of MV’s co-evolution with the host, the V protein may have acquired the ability to interact
380
with and modulate various host proteins such that the virus has gained better fitness.
381
IL-1β-treated dendritic cells show enhanced capacity to stimulate T cells (30).
382
Furthermore, proper inflammasome activation is found to be important in combating viral
383
and bacterial infections (4, 19, 21, 24). These observations may suggest that inhibition of
22
Downloaded from http://jvi.asm.org/ on November 1, 2017 by guest
366
inflammasome activation by the MV V protein may partly account for transient severe
385
immunosuppression during measles (15). In vivo studies using SLAM transgenic or
386
knock-in mice and recombinant viruses such as MVΔV would provide important insights
387
into mechanisms underlying immunological alterations caused by MV.
388
ACKNOWLEDGMENTS
389 390
We thank the staff of the Research Support Center, Graduate School of Medical Sciences,
391 392
Kyushu University for their technical support. This work was supported by grants from the
393
Ministry of Education, Culture, Sports, Science, and Technology, and the Ministry of
394
Health, Labour, and Welfare of Japan, and the Kanae Foundation for the Promotion of
395
Medical Science.
396
REFERENCES
397 398 399
1.
Allen, I. C., M. A. Scull, C. B. Moore, E. K. Holl, E. McElvania-TeKippe, D. J.
400
Taxman, E. H. Guthrie, R. J. Pickles, and J. P. Ting. 2009. The NLRP3
401
inflammasome mediates in vivo innate immunity to influenza A virus through
23
Downloaded from http://jvi.asm.org/ on November 1, 2017 by guest
384
recognition of viral RNA. Immunity 30:556-65.
402 403
2.
Andrejeva, J., K. S. Childs, D. F. Young, T. S. Carlos, N. Stock, S. Goodbourn, and R. E. Randall. 2004. The V proteins of paramyxoviruses bind the
405
IFN-inducible RNA helicase, mda-5, and inhibit its activation of the IFN-beta
406
promoter. Proc Natl Acad Sci U S A 101:17264-9.
407
3.
Bauernfeind, F., A. Ablasser, E. Bartok, S. Kim, J. Schmid-Burgk, T. Cavlar,
408
and V. Hornung. 2011. Inflammasomes: current understanding and open questions.
409
Cell Mol Life Sci 68:765-83.
410
4.
Brodsky, I. E., and D. Monack. 2009. NLR-mediated control of inflammasome
411
assembly in the host response against bacterial pathogens. Semin Immunol
412
21:199-207.
413
5.
Bryan, N. B., A. Dorfleutner, Y. Rojanasakul, and C. Stehlik. 2009. Activation of
414
inflammasomes requires intracellular redistribution of the apoptotic speck-like
415
protein containing a caspase recruitment domain. J Immunol 182:3173-82.
416
6.
the causes of death in children. Lancet 365:1147-52.
417 418 419
Bryce, J., C. Boschi-Pinto, K. Shibuya, and R. E. Black. 2005. WHO estimates of
7.
Burckstummer, T., C. Baumann, S. Bluml, E. Dixit, G. Durnberger, H. Jahn, M. Planyavsky, M. Bilban, J. Colinge, K. L. Bennett, and G. Superti-Furga. 2009.
24
Downloaded from http://jvi.asm.org/ on November 1, 2017 by guest
404
420
An orthogonal proteomic-genomic screen identifies AIM2 as a cytoplasmic DNA
421
sensor for the inflammasome. Nat Immunol 10:266-72.
422
8.
Caignard, G., M. Bourai, Y. Jacob, F. Tangy, and P. O. Vidalain. 2009. Inhibition of IFN-alpha/beta signaling by two discrete peptides within measles virus
424
V protein that specifically bind STAT1 and STAT2. Virology 383:112-20.
425
9.
Caignard, G., M. Guerbois, J. L. Labernardiere, Y. Jacob, L. M. Jones, F. Wild,
426
F. Tangy, and P. O. Vidalain. 2007. Measles virus V protein blocks Jak1-mediated
427
phosphorylation of STAT1 to escape IFN-alpha/beta signaling. Virology
428
368:351-62.
429
10.
Chuang, Y. T., Y. C. Lin, K. H. Lin, T. F. Chou, W. C. Kuo, K. T. Yang, P. R. Wu,
430
R. H. Chen, A. Kimchi, and M. Z. Lai. 2011. Tumor suppressor death-associated
431
protein kinase is required for full IL-1beta production. Blood 117:960-70.
432
11.
Devaux, P., V. von Messling, W. Songsungthong, C. Springfeld, and R. Cattaneo.
433
2007. Tyrosine 110 in the measles virus phosphoprotein is required to block STAT1
434
phosphorylation. Virology 360:72-83.
435
12.
Fernandes-Alnemri, T., J. W. Yu, P. Datta, J. Wu, and E. S. Alnemri. 2009.
436
AIM2 activates the inflammasome and cell death in response to cytoplasmic DNA.
437
Nature 458:509-13.
25
Downloaded from http://jvi.asm.org/ on November 1, 2017 by guest
423
438
13.
Fontana, J. M., B. Bankamp, W. J. Bellini, and P. A. Rota. 2008. Regulation of
439
interferon signaling by the C and V proteins from attenuated and wild-type strains
440
of measles virus. Virology 374:71-81. 14.
strategies for evading the interferon response. Rev Med Virol 12:337-57.
442 443
Gotoh, B., T. Komatsu, K. Takeuchi, and J. Yokoo. 2002. Paramyxovirus
15.
Griffin, D. E. 2007. Measles virus.p. 1551-1585. In D. M. Knipe, P. M. Howley, D.
444
E. Griffin, R. A. Lamb, M. A. Martin, B. Roizman, and S. E. Straus (ed.), Fields
445
virology, 5th ed. Lippincott Williams & Wilkins, Philadelphia.
446
16.
Guarda, G., M. Braun, F. Staehli, A. Tardivel, C. Mattmann, I. Forster, M.
447
Farlik, T. Decker, R. A. Du Pasquier, P. Romero, and J. Tschopp. 2011. Type I
448
interferon inhibits interleukin-1 production and inflammasome activation. Immunity
449
34:213-23.
450
17.
Hashimoto, K., N. Ono, H. Tatsuo, H. Minagawa, M. Takeda, K. Takeuchi, and
451
Y. Yanagi. 2002. SLAM (CD150)-independent measles virus entry as revealed by
452
recombinant virus expressing green fluorescent protein. J Virol 76:6743-9.
453
18.
Hornung, V., A. Ablasser, M. Charrel-Dennis, F. Bauernfeind, G. Horvath, D. R.
454
Caffrey, E. Latz, and K. A. Fitzgerald. 2009. AIM2 recognizes cytosolic dsDNA
455
and forms a caspase-1-activating inflammasome with ASC. Nature 458:514-8.
26
Downloaded from http://jvi.asm.org/ on November 1, 2017 by guest
441
456
19.
Ichinohe, T., H. K. Lee, Y. Ogura, R. Flavell, and A. Iwasaki. 2009.
457
Inflammasome recognition of influenza virus is essential for adaptive immune
458
responses. J Exp Med 206:79-87. 20.
inflammasomes via its intracellular M2 ion channel. Nat Immunol 11:404-10.
460 461
Ichinohe, T., I. K. Pang, and A. Iwasaki. 2010. Influenza virus activates
21.
Ichinohe, T., I. K. Pang, Y. Kumamoto, D. R. Peaper, J. H. Ho, T. S. Murray,
462
and A. Iwasaki. 2011. Microbiota regulates immune defense against respiratory
463
tract influenza A virus infection. Proc Natl Acad Sci U S A 108:5354-9.
464
22.
Ikegame, S., M. Takeda, S. Ohno, Y. Nakatsu, Y. Nakanishi, and Y. Yanagi.
465
2010. Both RIG-I and MDA5 RNA helicases contribute to the induction of
466
alpha/beta interferon in measles virus-infected human cells. J Virol 84:372-9.
467
23.
Johnston, J. B., J. W. Barrett, S. H. Nazarian, M. Goodwin, D. Ricciuto, G.
468
Wang, and G. McFadden. 2005. A poxvirus-encoded pyrin domain protein
469
interacts with ASC-1 to inhibit host inflammatory and apoptotic responses to
470
infection. Immunity 23:587-98.
471
24.
infection. Nat Rev Immunol 10:688-98.
472 473
Kanneganti, T. D. 2010. Central roles of NLRs and inflammasomes in viral
25.
Katze, M. G., Y. He, and M. Gale, Jr. 2002. Viruses and interferon: a fight for
27
Downloaded from http://jvi.asm.org/ on November 1, 2017 by guest
459
supremacy. Nat Rev Immunol 2:675-87.
474 475
26.
Kettle, S., A. Alcami, A. Khanna, R. Ehret, C. Jassoy, and G. L. Smith. 1997. Vaccinia virus serpin B13R (SPI-2) inhibits interleukin-1beta-converting enzyme
477
and protects virus-infected cells from TNF- and Fas-mediated apoptosis, but does
478
not prevent IL-1beta-induced fever. J Gen Virol 78 ( Pt 3):677-85.
479
27.
retrovirus-mediated expression cloning. Methods Mol Biol 134:143-52.
480 481
Kitamura, T., and Y. Morikawa. 2000. Isolation of T-cell antigens by
28.
Komiyama, T., C. A. Ray, D. J. Pickup, A. D. Howard, N. A. Thornberry, E. P.
482
Peterson, and G. Salvesen. 1994. Inhibition of interleukin-1 beta converting
483
enzyme by the cowpox virus serpin CrmA. An example of cross-class inhibition. J
484
Biol Chem 269:19331-7.
485
29.
Kraus, T. A., L. Garza, and C. M. Horvath. 2008. Enabled interferon signaling
486
evasion in an immune-competent transgenic mouse model of parainfluenza virus 5
487
infection. Virology 371:196-205.
488
30.
Kruse, M., E. Meinl, G. Henning, C. Kuhnt, S. Berchtold, T. Berger, G. Schuler,
489
and A. Steinkasserer. 2001. Signaling lymphocytic activation molecule is
490
expressed on mature CD83+ dendritic cells and is up-regulated by IL-1 beta. J
491
Immunol 167:1989-95.
28
Downloaded from http://jvi.asm.org/ on November 1, 2017 by guest
476
492
31.
Li, T., X. Chen, K. C. Garbutt, P. Zhou, and N. Zheng. 2006. Structure of DDB1
493
in complex with a paramyxovirus V protein: viral hijack of a propeller cluster in
494
ubiquitin ligase. Cell 124:105-17. 32.
the body. Annu Rev Immunol 27:229-65.
496 497
33.
Morita, S., T. Kojima, and T. Kitamura. 2000. Plat-E: an efficient and stable system for transient packaging of retroviruses. Gene Ther 7:1063-6.
498 499
Martinon, F., A. Mayor, and J. Tschopp. 2009. The inflammasomes: guardians of
34.
Nakatsu, Y., M. Takeda, S. Ohno, Y. Shirogane, M. Iwasaki, and Y. Yanagi.
500
2008. Measles virus circumvents the host interferon response by different actions of
501
the C and V proteins. J Virol 82:8296-306.
502
35.
high-expression transfectants with a novel eukaryotic vector. Gene 108:193-9.
503 504
Niwa, H., K. Yamamura, and J. Miyazaki. 1991. Efficient selection for
36.
Ohno, S., N. Ono, M. Takeda, K. Takeuchi, and Y. Yanagi. 2004. Dissection of
505
measles virus V protein in relation to its ability to block alpha/beta interferon signal
506
transduction. J Gen Virol 85:2991-9.
507
37.
Ono, N., H. Tatsuo, Y. Hidaka, T. Aoki, H. Minagawa, and Y. Yanagi. 2001.
508
Measles viruses on throat swabs from measles patients use signaling lymphocytic
509
activation molecule (CDw150) but not CD46 as a cellular receptor. J Virol
29
Downloaded from http://jvi.asm.org/ on November 1, 2017 by guest
495
75:4399-401.
510 511
38.
Palosaari, H., J. P. Parisien, J. J. Rodriguez, C. M. Ulane, and C. M. Horvath. 2003. STAT protein interference and suppression of cytokine signal transduction by
513
measles virus V protein. J Virol 77:7635-44.
514
39.
Parisien, J. P., D. Bamming, A. Komuro, A. Ramachandran, J. J. Rodriguez, G.
515
Barber, R. D. Wojahn, and C. M. Horvath. 2009. A shared interface mediates
516
paramyxovirus interference with antiviral RNA helicases MDA5 and LGP2. J Virol
517
83:7252-60.
518
40.
Park, E. K., H. S. Jung, H. I. Yang, M. C. Yoo, C. Kim, and K. S. Kim. 2007.
519
Optimized THP-1 differentiation is required for the detection of responses to weak
520
stimuli. Inflamm Res 56:45-50.
521
41.
Petit, F., S. Bertagnoli, J. Gelfi, F. Fassy, C. Boucraut-Baralon, and A. Milon.
522
1996. Characterization of a myxoma virus-encoded serpin-like protein with activity
523
against interleukin-1 beta-converting enzyme. J Virol 70:5860-6.
524
42.
Pfaller, C. K., and K. K. Conzelmann. 2008. Measles virus V protein is a decoy
525
substrate for IkappaB kinase alpha and prevents Toll-like receptor 7/9-mediated
526
interferon induction. J Virol 82:12365-73.
527
43.
Plumet, S., F. Herschke, J. M. Bourhis, H. Valentin, S. Longhi, and D. Gerlier.
30
Downloaded from http://jvi.asm.org/ on November 1, 2017 by guest
512
528
2007. Cytosolic 5'-triphosphate ended viral leader transcript of measles virus as
529
activator of the RIG I-mediated interferon response. PLoS One 2:e279.
530
44.
Poeck, H., M. Bscheider, O. Gross, K. Finger, S. Roth, M. Rebsamen, N. Hannesschlager, M. Schlee, S. Rothenfusser, W. Barchet, H. Kato, S. Akira, S.
532
Inoue, S. Endres, C. Peschel, G. Hartmann, V. Hornung, and J. Ruland. 2010.
533
Recognition of RNA virus by RIG-I results in activation of CARD9 and
534
inflammasome signaling for interleukin 1 beta production. Nat Immunol 11:63-9.
535
45.
Rajan, J. V., D. Rodriguez, E. A. Miao, and A. Aderem. 2011. The NLRP3
536
inflammasome detects encephalomyocarditis virus and vesicular stomatitis virus
537
infection. J Virol 85:4167-72.
538
46.
Ramachandran, A., and C. M. Horvath. 2010. Dissociation of paramyxovirus
539
interferon evasion activities: universal and virus-specific requirements for
540
conserved V protein amino acids in MDA5 interference. J Virol 84:11152-63.
541
47.
Ramachandran, A., J. P. Parisien, and C. M. Horvath. 2008. STAT2 is a primary
542
target for measles virus V protein-mediated alpha/beta interferon signaling
543
inhibition. J Virol 82:8330-8.
544 545
48.
Randall, R. E., and S. Goodbourn. 2008. Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures. J Gen
31
Downloaded from http://jvi.asm.org/ on November 1, 2017 by guest
531
Virol 89:1-47.
546 547
49.
Rathinam, V. A., Z. Jiang, S. N. Waggoner, S. Sharma, L. E. Cole, L. Waggoner, S. K. Vanaja, B. G. Monks, S. Ganesan, E. Latz, V. Hornung, S. N. Vogel, E.
549
Szomolanyi-Tsuda, and K. A. Fitzgerald. The AIM2 inflammasome is essential
550
for host defense against cytosolic bacteria and DNA viruses. Nat Immunol
551
11:395-402.
552
50.
Roberts, T. L., A. Idris, J. A. Dunn, G. M. Kelly, C. M. Burnton, S. Hodgson, L.
553
L. Hardy, V. Garceau, M. J. Sweet, I. L. Ross, D. A. Hume, and K. J. Stacey.
554
2009. HIN-200 proteins regulate caspase activation in response to foreign
555
cytoplasmic DNA. Science 323:1057-60.
556
51.
Schlender, J., V. Hornung, S. Finke, M. Gunthner-Biller, S. Marozin, K.
557
Brzozka, S. Moghim, S. Endres, G. Hartmann, and K. K. Conzelmann. 2005.
558
Inhibition of toll-like receptor 7- and 9-mediated alpha/beta interferon production in
559
human plasmacytoid dendritic cells by respiratory syncytial virus and measles virus.
560
J Virol 79:5507-15.
561
52.
sensor for metabolic danger? Science 327:296-300.
562 563
Schroder, K., R. Zhou, and J. Tschopp. 2010. The NLRP3 inflammasome: a
53.
Schuhmann, K. M., C. K. Pfaller, and K. K. Conzelmann. 2011. The Measles
32
Downloaded from http://jvi.asm.org/ on November 1, 2017 by guest
548
564
Virus V Protein Binds to p65 (RelA) To Suppress NF-{kappa}B Activity. J Virol
565
85:3162-71.
566
54.
55.
Shirogane, Y., M. Takeda, M. Tahara, S. Ikegame, T. Nakamura, and Y. Yanagi.
569
2010. Epithelial-mesenchymal transition abolishes the susceptibility of polarized
570
epithelial cell lines to measles virus. J Biol Chem 285:20882-90.
571
56.
Stasakova, J., B. Ferko, C. Kittel, S. Sereinig, J. Romanova, H. Katinger, and A.
572
Egorov. 2005. Influenza A mutant viruses with altered NS1 protein function
573
provoke caspase-1 activation in primary human macrophages, resulting in fast
574
apoptosis and release of high levels of interleukins 1beta and 18. J Gen Virol
575
86:185-95.
576
57.
Takaki, H., Y. Watanabe, M. Shingai, H. Oshiumi, M. Matsumoto, and T. Seya.
577
2011. Strain-to-strain difference of V protein of measles virus affects
578
MDA5-mediated IFN-beta-inducing potential. Mol Immunol 48:497-504.
579
58.
Takeda, M., S. Ohno, F. Seki, Y. Nakatsu, M. Tahara, and Y. Yanagi. 2005. Long
580
untranslated regions of the measles virus M and F genes control virus replication
581
and cytopathogenicity. J Virol 79:14346-54.
33
Downloaded from http://jvi.asm.org/ on November 1, 2017 by guest
inhibits the type I interferon response. Virology 315:389-97.
567 568
Shaffer, J. A., W. J. Bellini, and P. A. Rota. 2003. The C protein of measles virus
582
59.
Takeuchi, K., S. I. Kadota, M. Takeda, N. Miyajima, and K. Nagata. 2003.
583
Measles virus V protein blocks interferon (IFN)-alpha/beta but not IFN-gamma
584
signaling by inhibiting STAT1 and STAT2 phosphorylation. FEBS Lett 545:177-82. 60.
cellular receptor for measles virus. Nature 406:893-7.
586 587
Tatsuo, H., N. Ono, K. Tanaka, and Y. Yanagi. 2000. SLAM (CDw150) is a
61.
Thomas, P. G., P. Dash, J. R. Aldridge, Jr., A. H. Ellebedy, C. Reynolds, A. J.
588
Funk, W. J. Martin, M. Lamkanfi, R. J. Webby, K. L. Boyd, P. C. Doherty, and
589
T. D. Kanneganti. 2009. The intracellular sensor NLRP3 mediates key innate and
590
healing responses to influenza A virus via the regulation of caspase-1. Immunity
591
30:566-75.
592
62.
Tsuchiya, S., Y. Kobayashi, Y. Goto, H. Okumura, S. Nakae, T. Konno, and K.
593
Tada. 1982. Induction of maturation in cultured human monocytic leukemia cells
594
by a phorbol diester. Cancer Res 42:1530-6.
595
63.
Willingham, S. B., D. T. Bergstralh, W. O'Connor, A. C. Morrison, D. J.
596
Taxman, J. A. Duncan, S. Barnoy, M. M. Venkatesan, R. A. Flavell, M.
597
Deshmukh, H. M. Hoffman, and J. P. Ting. 2007. Microbial pathogen-induced
598
necrotic
599
CIAS1/cryopyrin/NLRP3 and ASC. Cell Host Microbe 2:147-59.
cell
death
mediated
by
34
the
inflammasome
components
Downloaded from http://jvi.asm.org/ on November 1, 2017 by guest
585
600
64.
Yokota, S., H. Saito, T. Kubota, N. Yokosawa, K. Amano, and N. Fujii. 2003. Measles virus suppresses interferon-alpha signaling pathway: suppression of Jak1
602
phosphorylation and association of viral accessory proteins, C and V, with
603
interferon-alpha receptor complex. Virology 306:135-46.
604 605
FIGURE LEGENDS
606 607
FIG. 1. Caspase-1-dependent IL-1β production by MV-infected THP-1 cells. (A) THP-1
608
(red line) and THP-1/PMA cells (blue line) were stained with anti-SLAM antibody IPO-3
609
or mouse IgG1 control antibody (THP-1 cells, shaded histogram), followed by staining
610
with FITC-labeled anti-mouse IgG. (B, C) THP-1/PMA cells were infected with MV or
611
influenza virus. Cell-free supernatants were collected at 24 h post-infection (B) or indicated
612
time points (C) and analyzed for IL-1β using an ELISA. (D) Immunoblot analysis of the
613
mature (p17) form of IL-1β in the supernatants (Sup) and pro- IL-1β in cell extracts (Cell)
614
of the cells infected with MV at indicated MOIs. (E) The effect of YVAD-CHO on IL-1β
615
and pro-IL-1β production was determined in THP-1/PMA cells at 24 h after MV infection.
616
N.D., not detected. (F) THP-1/PMA cells were inoculated with live or UV-inactivated MV.
617
Cell-free supernatants and cell lysates were collected at 24 h post-infection and analyzed
35
Downloaded from http://jvi.asm.org/ on November 1, 2017 by guest
601
618
for IL-1β by ELISA. The value represents the mean ± the standard deviation of triplicate
619
samples. The data shown are representative of three different experiments. *, P < 0.05; ***,
620
P < 0.001.
622
FIG. 2. NLRP3 inflammasome activation by MV. (A) Expression levels of NLRP3, and
623
RIG-I in PMA-stimulated THP-1 cells expressing shRNA targeting NLRP3, RIG-I,
624
irrelevant molecule (Control) or EGFP were examined by western blot analysis at 24 h after
625
LPS (1μg/ml) stimulation. β-actin was used as an internal control. (B–D) PMA-stimulated
626
THP-1 cells expressing shRNA targeting NLRP3, RIG-I or EGFP were treated with LPS (5
627
ng/ml) or LPS (5 ng/ml) plus ATP (5 mM; B), MV (C) or poly(dA:dT) (400 ng/ml; D).
628
Cell-free supernatants were collected 24 h after treatment, and analyzed for IL-1β by
629
ELISA. n.d., not detected. The values represent the mean ± the standard deviation of
630
triplicate samples. The data shown are representative of at least three different experiments.
631
**, P < 0.01; ***, P < 0.001.
632 633
FIG. 3. Inhibition of NLRP3 inflammasome-mediated IL-1β secretion by the MV V
634
protein. (A) HEK293T cells were transfected with expression plasmids encoding NLRP3,
635
ASC, procaspase-1, and pro-IL-1β, together with the expression plasmid encoding the MV
36
Downloaded from http://jvi.asm.org/ on November 1, 2017 by guest
621
V protein or control plasmid (indicated by –). Cell-free supernatants were collected 24 h
637
after transfection, and analyzed for IL-1β by ELISA. (B) Expression of the V protein in
638
THP-1 cells stably expressing the MV V protein or EGFP were examined by western blot
639
analysis. (C, D) PMA-stimulated THP-1 cells stably expressing the MV V protein or EGFP
640
were stimulated with LPS (5 ng/ml) plus ATP (0, 2.5 or 5 mM; C) or poly(dA:dT) (400
641
ng/ml; D). (E) THP-1/PMA cells were infected with wild-type MV or MVΔV virus.
642
Cell-free supernatants and cell lysates were collected at 24 h post infection and analyzed for
643
IL-1β and pro-IL-1β by ELISA, respectively. The values represent the mean ± the standard
644
deviation of triplicate samples. The data shown are representative of three different
645
experiments. *, P < 0.05; **, P < 0.01; ***, P < 0.001.
646 647
FIG. 4. Interaction of the MV V protein with NLRP3. (A) HEK293T cells were
648
transfected with expression plasmids encoding HA-tagged V protein and either Flag-tagged
649
NLPR3, ASC, MDA5 or empty vector. Proteins were immunoprecipitated 48 h later with
650
anti-Flag antibody, followed by immunoblot analysis of total lysates (INPUT) and
651
immunoprecipitates (IP) with indicated antibodies (anti-Flag or anti-HA). (B) V, Vn (upper
652
and middle panels) and Vc (lower panel) were examined for their interaction with NLRP3
653
as described in (A). (C) Vc and Vc with the C272R substitution (VcC272R) were examined
37
Downloaded from http://jvi.asm.org/ on November 1, 2017 by guest
636
for their interaction with NLRP3 as described in (A). Vc and VcC272R were expressed as
655
fusion proteins with kusabira-orange, so that the control HA-empty plasmid directed the
656
production of the kusabira-orange peptide that was detected with anti-HA tag antibody. (D)
657
PMA-stimulated THP-1/MV-V cells were treated with LPS (5 ng/ml) and ATP (5 mM) or
658
left untreated for 6 h, and examined for the localization of NLRP3 and MV V proteins. The
659
data shown are representative of at least three different experiments.
660
38
Downloaded from http://jvi.asm.org/ on November 1, 2017 by guest
654
Downloaded from http://jvi.asm.org/ on November 1, 2017 by guest
Downloaded from http://jvi.asm.org/ on November 1, 2017 by guest
Downloaded from http://jvi.asm.org/ on November 1, 2017 by guest
Downloaded from http://jvi.asm.org/ on November 1, 2017 by guest